drugset / Trial / NCT07230496
A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healthy Overweight/Obese Participants
RandomizedParallel-groupQuadruple-blindBasic science
Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of LAE103 injection in healthy overweight/obese participants or healthy postmenopausal women. Study will also evaluate the safety, tolerability and preliminary pharmacodynamic effect of multiple dose injections in overweight/obese participants. In addition, the study will also investigate the safety, tolerability of a single-dose co-administration of LAE102 and LAE103 in healthy overweight/obese participants.
Timeline
- Start
- 2025-12-30
- Primary completion
- 2028-03-20
- Completion
- 2028-03-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LAE102 | Unknown | — | Subcutaneous |
| Subject | LAE103 | Unknown | — | Subcutaneous |
Indications
No indication recorded.